SG Americas Securities’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.52M Sell
5,899
-13,010
-69% -$3.46M ﹤0.01% 1522
2025
Q4
$4.66M Buy
18,909
+15,591
+470% +$3.28M 0.01% 1124
2025
Q3
$586K Sell
3,318
-9,289
-74% -$1.39M ﹤0.01% 1983
2025
Q2
$1.73M Buy
12,607
+11,295
+861% +$1.66M 0.01% 845
2025
Q1
$237K Buy
+1,312
New +$221K ﹤0.01% 2414
2024
Q4
Sell
-2,527
Closed -$460K 3378
2024
Q3
$460K Buy
2,527
+1,765
+232% +$340K ﹤0.01% 1758
2024
Q2
$140K Sell
762
-6,245
-89% -$1.05M ﹤0.01% 2358
2024
Q1
$1.25M Sell
7,007
-11,858
-63% -$1.65M 0.01% 1056
2023
Q4
$2.34M Sell
18,865
-2,074
-10% -$230K 0.03% 616
2023
Q3
$2.43M Buy
+20,939
New +$2.55M 0.03% 620
2023
Q2
Sell
-5,714
Closed -$457K 2751
2023
Q1
$457K Sell
5,714
-33,060
-85% -$2.6M 0.01% 1784
2022
Q4
$3.07M Buy
38,774
+36,434
+1,557% +$2.7M 0.05% 402
2022
Q3
$163K Sell
2,340
-20,130
-90% -$1.45M ﹤0.01% 2487
2022
Q2
$1.48M Sell
22,470
-16,631
-43% -$1.03M 0.02% 954
2022
Q1
$2.6M Sell
39,101
-13,369
-25% -$834K 0.02% 728
2021
Q4
$3.67M Buy
52,470
+288
+0.6% +$16.8K 0.02% 652
2021
Q3
$2.72M Buy
52,182
+16,141
+45% +$956K 0.01% 1006
2021
Q2
$2.45M Sell
36,041
-1,709
-5% -$119K 0.01% 994
2021
Q1
$2.91M Sell
37,750
-5,238
-12% -$381K 0.02% 801
2020
Q4
$2.58M Sell
42,988
-13,891
-24% -$694K 0.02% 918
2020
Q3
$2.45M Buy
56,879
+36,203
+175% +$1.57M 0.02% 629
2020
Q2
$856K Buy
+20,676
New +$995K 0.01% 1566

Other funds holding KRYS